Targa Resources Stock Rises As Wall Street Hikes Price Targets

Targa Resources Inc. stocks have been trading up by 4.37 percent following strong midstream expansion news boosting investor optimism.

Spot the Next Big Runner

Click Here for a Millionaire's POV on Trading TRGP

SUBSCRIBE FOR ALERTS

JOIN 50,000+ ACTIVE TRADERS

What Traders Need To Know

Major banks including Citi, Goldman Sachs, Bank of America, Barclays, Stifel, Jefferies, and Scotiabank reaffirmed bullish ratings on Targa Resources Inc. (TRGP) with targets mostly in the high-$200s to mid-$300s.
RBC Capital Markets reiterated an Outperform and $338 target, highlighting strong Permian volumes, returning Waha-related volumes, and long-duration contracts supporting second-half 2026 results.
Several firms flagged weaker Waha spreads and a sharp quarter-over-quarter marketing loss as near-term earnings headwinds, but still expect outsized growth backed by Targa Resources Inc.’s deal with Exxon.
A Q3 2026 cash dividend of $1.25 per share ($5.00 annualized) and the scheduled earnings webcast add income appeal and a clear near-term catalyst for TRGP.
Scotiabank expects more typical activity and moderated momentum for U.S. midstream stocks in the second half, even as it maintains an Outperform on Targa Resources Inc.

Weekly Update Oct 12 – Oct 16, 2026: On Friday, October 16, 2026 Targa Resources Inc. stock [NYSE: TRGP] is trending up by 4.37%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Energy industry expert:

Analyst sentiment – positive

Targa Resources (TRGP) sits in the top tier of North American midstream, with strong asset density in the Permian and attractive integrated NGL value chain economics. Fundamentals are robust: Q2 revenue of $4.44 billion with a 38%+ EBITDA margin and ROIC around 20% confirm efficient deployment of capital. However, leverage is high (total debt-to-equity 5.2x, long-term debt-to-capital 84%), interest coverage only 2.8x, and liquidity tight (current ratio 0.8x), leaving little room for execution missteps. The 1.8% dividend yield understates total return potential but looks well-covered by $1.44 billion of operating cash flow and $431 million of quarterly free cash flow despite capex-heavy growth.

Price action on the weekly tape around $282–295 shows a steady uptrend with shallow pullbacks and consistent higher closes, confirming institutional accumulation in line with repeated target hikes. Intraday 5‑minute candles (not shown in detail) have recently respected the $282–285 zone as firm demand, with low-volume dips being bought and heavier volume on pushes toward $295. Dominant trend is bullish. A specific actionable level: buy against $282 support with a tight stop below $278, targeting a breakout through $295 toward the low $300s on continued volume confirmation.

More Breaking News

Catalysts skew decisively positive: multiple bulge-bracket banks have raised targets into the $319–338 range, citing strong Permian inlet volume growth, normalized Waha spreads as new takeaway pipes ramp, and the Exxon-linked growth corridor. TRGP trades below the ~$325–330 mean target, implying 10–15% upside versus broader midstream indices and key fossil fuel benchmarks that now offer mid‑single‑digit total return profiles. I see fair value at $320 over 6–12 months, with tactical resistance near $300–305 and strong support at $275–280.

Quick Financial Overview

Targa Resources Inc. sits at the center of a very bullish analyst backdrop. Citi, Goldman Sachs, and Bank of America all raised price targets into a $322–$330 band ahead of Q3 earnings, while RBC keeps a $338 target in place. Across recent notes, the mean target in the low-to-mid $320s still implies meaningful upside from the high-$280s to low-$290s trading area, even after a strong run. For traders, that consensus band effectively marks the current “street roadmap” for potential continuation.

On the tape, TRGP’s weekly data show price parked around $290–$295, with a recent print near $294.90 and only a brief dip to $282.55. That tight range after a modest pullback lines up with a bullish consolidation rather than a breakdown. Intraday, the 5-minute chart shows a steady grind from an early low in the $285–$287 zone up toward the close just under $295, with shallow dips being bought and no heavy-volume flushes visible in the data provided.

Under the hood, the fundamentals support that strength. Revenue over the last year runs near $17.03B, with gross margin close to 49.8% and EBITDA margin above 40%, solid numbers for a midstream name. Returns on equity are high, with return on equity last twelve months above 70%, but that comes with heavy leverage: total debt to equity above 5 and a current ratio under 1. The company still throws off solid cash flow, with quarterly operating cash flow of about $1.44B and free cash flow around $431.2M, supporting a $5.00 annual dividend (roughly a 1.8% yield) that was reaffirmed for Q3 2026.

Conclusion

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.

Start Your Trial Now!